The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly a...
FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange in New York, U.S., May 18, 2018. REUTERS/Brendan McDermid
- The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co’s migraine drug, Reyvow. The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults.worth about $960 million when it bought CoLucid Pharmaceuticals Inc in early 2017. Lasmiditan was first developed at Lilly, but later licensed out to CoLucid in 2005.According to the Migraine Research Foundation, roughly 39 million Americans suffer from migraine headaches.
The FDA advises patients not to drive or operate machinery for at least eight hours after taking Reyvow, as the drug causes dizziness and sedation.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Viagra May Enhance Stem Cell Treatments For LeukemiaViagra when combined with another FDA-approved drug may enhance the collection of blood stem cells, used in the treatment of leukemia and several other diseases.
Weiterlesen »
Pompeo says Orwell's '1984' coming to life in China's Xinjiang regionU.S. Secretary of State Mike Pompeo on Friday likened China's treatment of ...
Weiterlesen »
Australia housing in 'mini-boom' but signs bleak elsewhere in economyApprovals for new home loans in Australia jumped for a second consecutive month ...
Weiterlesen »